[144] KANZHUN LIMITED SEC Filing
Rhea-AI Filing Summary
Kanzhun Limited (BZ) filing a Form 144 reports a proposed sale of 70,000 American Depositary Shares (ADS), each ADS representing two Class A ordinary shares, on Nasdaq with an aggregate market value of $1,647,800. The filing lists total shares outstanding of 951,183,832. The planned approximate date of sale is 08/22/2025 and the broker named is Futu Securities International (Hong Kong) Limited.
The ADS to be sold were acquired by the seller through multiple employee equity incentive awards on dates between 03/18/2024 and 08/22/2025, with individual award sizes reported (for example, 34,000 shares on 12/17/2024 and 27,448 on 03/17/2025). The filer certifies they are not aware of undisclosed material adverse information.
Positive
- Transparency: Filing specifies broker, exact ADS quantity (70,000), aggregate market value ($1,647,800), and planned sale date (08/22/2025).
- Origin of shares disclosed: All securities to be sold are identified as employee equity incentive awards with acquisition dates and amounts.
Negative
- No financial context: Filing contains no earnings, liquidity, or operational data to assess broader company impact.
- No recent sales reported: While not necessarily negative, the form notes "Nothing to Report" for securities sold in the past three months, limiting trend visibility.
Insights
TL;DR: Routine insider sale notice for 70,000 ADS valued at $1.65M; no financial results or disclosures beyond transaction details.
The Form 144 documents a proposed sale under Rule 144 rather than an open-market disclosure of company performance. The filing identifies the broker, number of ADS, aggregate value, and acquisition dates tied to employee equity awards. This provides transparency about timing and origin of the securities but does not include earnings, liquidity, or strategic information. The filing does not report any securities sold in the prior three months.
TL;DR: Governance disclosure appears complete for a Rule 144 notice; signer affirms absence of undisclosed material adverse information.
The document includes required representations and signature warnings about material information and false statements. It itemizes grant dates and amounts for the securities to be sold, indicating the holdings arise from employee incentive awards. The filing does not indicate gifts, aggregated sales issues, or trading-plan dates.